Mount Lab Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.25 M
as on 08-07-2024
- Revenue 10.98%
(FY 2020)
- Profit 7.92%
(FY 2020)
- Ebitda 32.65%
(FY 2020)
- Net Worth 73.88%
(FY 2020)
- Total Assets 6.40%
(FY 2020)
About Mount Lab Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.25 M.
Jaganathan, Sudhakar Vilvanathan, and Vilvanathan Thirunavukkarasu serve as directors at the Company.
- CIN/LLPIN
U33119TN2016PTC103787
- Company No.
103787
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mount Lab Products?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhakar Vilvanathan  | Director | 22-Jan-2016 | Current |
| Jaganathan | Director | 22-Jan-2016 | Current |
| Vilvanathan Thirunavukkarasu | Director | 22-Jan-2016 | Current |
Financial Performance of Mount Lab Products.
Mount Lab Products Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 10.98% increase. The company also saw a slight improvement in profitability, with a 7.92% increase in profit. The company's net worth Soared by an impressive increase of 73.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mount Lab Products?
In 2020, Mount Lab Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sudhagar Biological And Chemicals Private LimitedActive 2 years 7 monthsJaganathan, Sudhakar Vilvanathan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 18 Jul 2020 | ₹0.75 M | Open |
Indian Bank Creation Date: 18 Dec 2017 | ₹4.50 M | Open |
How Many Employees Work at Mount Lab Products?
Unlock and access historical data on people associated with Mount Lab Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mount Lab Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mount Lab Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
